Search Result "PPAR- γ agonists"
A Review on the Development in the Field of NIDDM based Thiazolidinedione PPARγ Agonists
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 13 Issue: 5 Year: 2013 Page: 706-712
Author(s): Pooja S. Banerjee, Subir Samanta
PPAR- γ Agonist in Treatment of Diabetes: Cardiovascular Safety Considerations
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 10 Issue: 2 Year: 2012 Page: 124-134
Author(s): Aamer Abbas,Jimena Blandon,Jennifer Rude,Ahmed Elfar,Debabrata Mukherjee
Balaglitazone: A Second Generation Peroxisome Proliferator-Activated Receptor (PPAR) Gamma (γ) Agonist
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 12 Issue: 2 Year: 2012 Page: 87-97
Author(s): R. Agrawal, P. Jain, S. N. Dikshit
Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) as a Target for Concurrent Management of Diabetes and Obesity-Related Cancer
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 25 Year: 2017 Page: 3677-3688
Author(s): Qingqing Wang,Mustapha Umar Imam,Zhang Yida,Fudi Wang
Therapeutic Use of Agonists of the Nuclear Receptor PPARγ in Alzheimers Disease
Journal: Current Alzheimer Research
Volume: 4 Issue: 2 Year: 2007 Page: 159-164
Author(s): Gary Landreth
PPARγ Agonists in Combination Cancer Therapies
Journal: Current Cancer Drug Targets
Volume: 20 Issue: 3 Year: 2020 Page: 197-215
Author(s): Piotr Mrowka,Eliza Glodkowska-Mrowka
PPAR Modulators and PPAR Pan Agonists for Metabolic Diseases: The Next Generation of Drugs Targeting Peroxisome Proliferator-Activated Receptors?
Journal: Current Topics in Medicinal Chemistry
Volume: 8 Issue: 9 Year: 2008 Page: 728-749
Author(s): P. L. Feldman, M. H. Lambert, B. R. Henke
Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Agonists as Therapeutic Agents for Cardiovascular Disorders: Focus on Atherosclerosis
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 7 Year: 2017 Page: 1119-1124
Author(s): Ekaterina A. Ivanova,Veronika A. Myasoedova,Alexandra A. Melnichenko,Alexander N. Orekhov
Antineoplastic Effects of PPAR? Agonists, with a Special Focus on Thyroid Cancer
Journal: Current Medicinal Chemistry
Volume: 23 Issue: 7 Year: 2016 Page: 636-649
Author(s): Silvia Martina Ferrari, Gabriele Materazzi, Enke Baldini, Salvatore Ulisse, Paolo Miccoli, Alessandro Antonelli, Poupak Fallahi
Treatment of Anaplastic Thyroid Cancer: Is there a Role for PPARγ Agonists?
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 2 Issue: 3 Year: 2008 Page: 194-199
Author(s): Alessandro Antonelli, Silvia M. Ferrari, Poupak Fallahi, Piero Berti, Gabriele Materazzi, Emiliano Ghiri, Angelo Carpi, Andrea Nicolini, Paolo Miccoli